Chief Financial Officer (13) · BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Eyal Rubin

A named executive officer of BRAINSTORM CELL THERAPEUTICS in every fiscal year CompBrief holds from FY2017 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$351,000

Salary $197,000Stock awards $0Bonus $49,000

FY2017: $382,250

3rd of 3 named executive officers at Brainstorm Cell Therapeutics by FY2018 total.

3 named officers on file for BRAINSTORM CELL THERAPEUTICS, FY2018

Eyal Rubin’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how BRAINSTORM CELL THERAPEUTICS’s whole pay program stands against its peers

  • BRAINSTORM CELL THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BCLI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 25, 2019 (DEF 14A).

Free

Get Eyal Rubin’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Eyal Rubin compensation by year

BRAINSTORM CELL THERAPEUTICS Summary Compensation Table · all 2 fiscal years held
In US dollars, as BRAINSTORM CELL THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018
Salary$20,200$197,000
Bonus$5,000$49,000
Stock awards$347,843$0
Option awards$0—
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$9,207$105,000
Total$382,250$351,000

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BRAINSTORM CELL THERAPEUTICS INC. DEF 14A filed October 25, 2019, accession 0001104659-19-056570, and prior-year filings.

How this page was built: the BRAINSTORM CELL THERAPEUTICS INC. filed document, accession 0001104659-19-056570. Every figure is read from that document and cited to the page and table it appears in. Filed October 25, 2019.

$382K
$351K
FY17
FY18
SalaryBonusStock awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
Option70,264—$4.30

Per the Outstanding Equity Awards at Fiscal Year-End table in BRAINSTORM CELL THERAPEUTICS INC.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

BRAINSTORM CELL THERAPEUTICS’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Chaim LebovitsPresident and CEO (4)$1,578,870
Ralph KernChief Operating Officer (9)$841,650
Eyal Rubin · this pageChief Financial Officer (13)$351,000

The full BRAINSTORM CELL THERAPEUTICS compensation record

free company brief

This page is one person within BRAINSTORM CELL THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BRAINSTORM CELL THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Eyal Rubin's compensation dossier · One-time report. No refunds.